Catherine M. Engelbert Royalty Pharma PLC (RPRX) insider trading activity

Catherine M. Engelbert is Director of Royalty Pharma plc. Currently has a direct ownership of 51,128 shares of RPRX, which is worth approximately $1.7 Million. The most recent transaction as insider was on May 13, 2025, when has been sold 7,614 shares (Class A Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 51.1K

17.5% 3M change

53.95% 12M change

Total Value Held $1.7 Million

Catherine M. Engelbert Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 13 2025	BUY Grant, award, or other acquisition	-	7,614 Added 12.96%	51,128 Class A Ordinary Shares
Jun 07 2024	BUY Grant, award, or other acquisition	-	9,293 Added 17.6%	43,514 Class A Ordinary Shares
Jun 23 2023	BUY Grant, award, or other acquisition	-	7,747 Added 18.91%	33,211 Class A Ordinary Shares
Jun 24 2022	BUY Grant, award, or other acquisition	-	6,328 Added 19.9%	25,464 Class A Ordinary Shares
Jun 25 2021	BUY Grant, award, or other acquisition	-	5,726 Added 23.03%	19,136 Class A Ordinary Shares
Sep 30 2020	BUY Grant, award, or other acquisition	$37,465 $41.17 p/Share	910 Added 6.35%	13,410 Class A Ordinary Shares

Also insider at

MCD

MCDONALDS CORP Consumer Cyclical

CME